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INTRODUCTION 
Cervical cancer is the third most common female cancer worldwide and the fourth leading 
cause of cancer death in women. Persistent infection of the uterine cervix with oncogenic 
high-risk types of human papillomavirus (HR-HPV), particularly HPV16, is recognized as the 
cause for the development of precancerous cervical lesions that may progress to invasive 
cancer.1 However, only a minority of women infected with HR-HPV develops premalignant 
and malignant lesions, suggesting that cofactors are involved in HR-HPV-associated 
carcinogenesis. 
Polyomaviridae  is a continuously growing family of viruses with up to 11 new human 
representatives recently added to the previously described BK polyomavirus (BKPyV) and JC 
polyomavirus (JCPyV).2 Human polyomaviruses (HPyVs) subclinically infect the general 
population and may induce disease in immunocompromised patients.2 Moreover, these viruses 
have the potential capacity to induce tumors through their tumor antigen (T-Ag) 
oncoproteins.2 The oncogenic capabilities of HPyVs were recently illustrated with the 
discovery of the Merkel cell polyomavirus (MCPyV), which is now commonly accepted as 
the etiologic agent of the Merkel cell carcinoma, a rare but aggressive skin cancer.3  
Several studies have investigated the presence of HPyVs in different tissues, and their 
presence in the female genital tract may suggest an association between HPyVs and 
precancerous or cancerous cervical lesions, as illustrated by the detection of BKPyV, JCPyV 
and MCPyV genomic sequences in cervical cancer cases.4-7  
In order to study more deeply the relationships between HPyVs, cervical lesions and immune 
status, we have investigated the presence of recently described HPyVs including MCPyV, 
HPyV6, HPyV7 and the Trichodysplasia spinulosa polyomavirus (TSPyV) in cervical 
samples from African and French women, in relation to HR-HPV co-infection, cervical 
disease stage, and HIV serostatus.  
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METHODS  
A total of 190 cervical samples collected with the Digene cervical sampler and placed in the 
specimen transport medium (STM) (Qiagen, Gaithersburg, MD) were analysed. One hundred 
and forty samples were collected from a subset of women with a median age of 35.4 years 
(range, 21-47 years) enrolled in the HARP (HPV in Africa Research Partnership) study, 
which is conducted in two Sub-Saharan African countries, South Africa and Burkina Faso, 
with the aim to evaluate cervical cancer screening approaches in HIV-1 infected African 
women. In addition, 50 samples were collected from randomly selected HIV-seronegative 
women with a median age of 40.0 years (range, 25-68 years) attending a gynaecological 
outpatient department at the Montpellier University Hospital, France, who were tested for 
HR-HPV infection. Cervical biopsies were obtained from all of the African women who had a 
positive HR-HPV test and/or abnormal cervical cytology and/or abnormal visual inspection 
using acetic acid and Lugol’s iodine, and these women were selected to provide similar 
proportions of women with high-grade lesions (CIN2+) and women with normal histological 
findings or low-grade lesions (<CIN1). In the group of French women, biopsies were 
performed only in case of abnormal cytological findings.  
Written informed consent was obtained from the women. Ethical approval was granted from 
Ministry of Health in Burkina Faso (no. 2012-12-089), the Witwatersrand University in South 
Africa (no. 110707), and the London School of Hygiene and Tropical Medicine (no. 7400). 
HR-HPV DNA was detected using the Hybrid Capture 2 assay (Qiagen) with subsequent 
HPV genotyping using the INNO-LiPA HPV Genotyping Extra assay (Furijebio, Les Ulis, 
France). 
DNA was extracted from STM using the NucliSens EasyMag extraction kit (Biomérieux, 
Craponne, France) with the NucliSens EasyMag automated extractor. Detection of 
MCPyV, HPyV6, HPyV7 and TSPyV DNA was performed by real-time PCR using specific 
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primers. Quantification of MCPyVs DNA was normalized to the amount of whole genomic 
DNA as previously described.8 For the other viruses, semi-quantification was based on the 
cycle threshold value (Ct) and samples with Ct>40 were considered as negative. 
Proportions were compared using the chi-square test or Fisher’s exact test, and the MCPyV 
DNA levels were compared using the Mann-Whitney U test. 
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RESULTS 
HR-HPV DNA was detected in cervical specimens from 124 (88.6%) HIV-1-positive African 
women and from 24 (48.0%) HIV-negative French women. HPV16 DNA was detected in 
cervical specimens from 36 (27.8%) African women and 6 (12.0%) French women. CIN2+ 
lesions were found in 65% (91/140) of the selected African women and 2% (1/50) of the 
French women. 
Overall, MCPyV, HPyV6, HPyV7 and TSPyV DNA was detected in 105 (55.3%), 6 (3.2%), 
4 (2.1%), and 0 (0%) samples, respectively.  MCPyV DNA loads were low, with a median 
MCPyV copy number of 80 copies/106 cells (range 14 to 210 copies/106 cells), the lower limit 
of detection (LLD) being 10 copies/106 cells. Median MCPyV DNA load was 79 copies/106 
cells in women without CIN2+ lesions and 83 copies/106 cells in women with CIN2+ lesions 
(p=0.75). HPyV6 and HPyV7 DNA levels were always weakly detected in the positive 
samples, with cycle thresholds ranging from 34 to 40.  
As shown in Table 1, there was no association between the detection of MCPyV DNA and 
HIV serostatus, the detection of HR-HPV, or the presence of CIN2+ cervical lesions. HPyV6 
(n=6) and HPV7 (n=4) were detected in 4 and 4 HIV-infected African women and 2 and 0 
HIV-negative French women, respectively (p=1.00). The small sample size did not allow for 
sufficient statistical power to validly analyse the association of HPyV6 and HPyV7 detection 
with HR-HPV infection and cervical lesions. 
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Table 1 Associations between MCPyV detection and geographic origin/HIV serostatus, HR-
HPV infection and cervical lesions 
 
 
Parameter 
MCPyV status   
 
 
P 
Positive 
(N=105) 
n (%) 
Negative 
(N=85) 
n (%) 
 
 
OR (95% CI) 
HIV  
   Positive* (n=140) 
   Negative (n=50) 
 
79 (56.4) 
26 (52.0) 
 
61 (43.6) 
24 (48.0) 
 
1.20 (0.60-2.40) 
 
0.588 
HR-HPV  
   Positive (n=148) 
   Negative (n=42) 
 
81 (54.7) 
24 (57.1) 
 
67 (45.2) 
18 (42.9) 
 
0.91 (0.43-1.91) 
 
0.781 
HPV16  
    Positive (n=45) 
     Negative (n=145) 
 
20 (44.4) 
85 (58.6) 
 
25 (55.6) 
60 (41.4) 
 
0.56 (0.27-1.17) 
 
0.095 
Cervical histology 
   CIN2+  (n=92) 
   ≤CIN1 (n=98) 
 
54 (58.7) 
51 (52.1) 
 
38 (41.3) 
47 (47.9) 
 
1.31 (0.71-2.42) 
 
0.356 
*All African women were HIV-1-positive and all French women were HIV-negative 
CIN2+, cervical intraepithelial neoplasia grade 2 or more severe 
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DISCUSSION 
This study, involved two very different populations of women in terms of geographic origin, 
HIV status, prevalence of HR-HPV infection and precancerous cervical lesions. Overall, 
MCPyV DNA was frequently detected at low levels in cervical specimens, whereas HPyV6 
and HPyV7 were rarely detected, and TSPyV was not detected. MCPyV DNA detection was 
not associated with HIV status, HR-HPV infection or precancerous cervical lesions. 
Moreover, MCPyV DNA levels were not different between women with or without 
precancerous lesions. The sample size of HPyV6/HPyV7 was too small for useful statistical 
comparisons.  
These results, which do not support a role of these human polyomaviruses in the development 
of cervical lesions, are in agreement with a recent study reporting a high frequency of 
MCPyV detection in cervical carcinomas but no statistically significant association between 
MCPyV infection and cervical cancer.7 These observations argue against a possible role of 
MCPyV as a cofactor of HPV-induced carcinogenesis. Interestingly, the detection rates of 
MCPyV, HPyV6, HPyV7 and TSPyV in cervical specimens observed in this study are similar 
to those reported in normal skin specimens, these viruses being considered as belonging to the 
skin microbiota.9,10 This observation suggests that MCPyV and, to a lesser extent, HPyV6 and 
HPyV7 might belong to the female genital tract microbiota. The transmission routes of these 
viruses and their mode of propagation to the female genital tract remain to be elucidated, and 
the hypothesis of genital mucosa contamination by skin viruses via hands or sexual activity 
cannot be excluded.    
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Key messages 
 MCPyV is frequently detected at low levels in cervical samples, whereas HPyV6, 
HPyV7 and TSPyV are rarely or not detected. 
 MCPyV detection is not associated with HIV status, HR-HPV infection or 
precancerous cervical lesions. 
 Polyomaviruses might belong to the female genital tract microbiota. 
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